Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells

Bin Yuan, Michael Sierks

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Intracellular clearance of toxic protein aggregates represents a promising therapeutic approach to treat protein-misfolding diseases such as Parkinson's and Huntington's diseases. Intracelluarly expressed antibody fragments or intrabodies can be used to bind specific intracellular targets. Addition of a non-traditional secretion signal sequence enables the intrabody to first bind its target inside the cell and then shuttle the bound target through the cell membrane, secreting it from the cell. We intracellularly expressed two different single chain antibody (scFv) fragments targeting either monomeric or oligomeric alpha-synuclein (a-syn), in a mammalian cell model that overexpresses a-syn. Two versions of each intrabody were studied, one with and one without the non-traditional secretion signal. The scFv targeting monomeric a-syn provided little or no reduction in toxicity induced by overexpression of a-syn, however binding and secretion of oligomeric a-syn totally reduced toxicity. Non-traditional intrabody secretion therefore represents an effective method to target and clear a variety of harmful intracellular species.

Original languageEnglish (US)
Pages (from-to)16-18
Number of pages3
JournalNeuroscience Letters
Volume459
Issue number1
DOIs
StatePublished - Jul 31 2009

Fingerprint

alpha-Synuclein
Immunoglobulin Fragments
Proteostasis Deficiencies
Single-Chain Antibodies
Poisons
Huntington Disease
Protein Sorting Signals
Parkinson Disease
Cell Membrane
Therapeutics

Keywords

  • Aggregation
  • Alpha-synuclein
  • Neuronal cells
  • Oligomer
  • Parkinson's disease
  • Toxicity

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells. / Yuan, Bin; Sierks, Michael.

In: Neuroscience Letters, Vol. 459, No. 1, 31.07.2009, p. 16-18.

Research output: Contribution to journalArticle

@article{3eea09a3eeec4f72a2625a53efc4d555,
title = "Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells",
abstract = "Intracellular clearance of toxic protein aggregates represents a promising therapeutic approach to treat protein-misfolding diseases such as Parkinson's and Huntington's diseases. Intracelluarly expressed antibody fragments or intrabodies can be used to bind specific intracellular targets. Addition of a non-traditional secretion signal sequence enables the intrabody to first bind its target inside the cell and then shuttle the bound target through the cell membrane, secreting it from the cell. We intracellularly expressed two different single chain antibody (scFv) fragments targeting either monomeric or oligomeric alpha-synuclein (a-syn), in a mammalian cell model that overexpresses a-syn. Two versions of each intrabody were studied, one with and one without the non-traditional secretion signal. The scFv targeting monomeric a-syn provided little or no reduction in toxicity induced by overexpression of a-syn, however binding and secretion of oligomeric a-syn totally reduced toxicity. Non-traditional intrabody secretion therefore represents an effective method to target and clear a variety of harmful intracellular species.",
keywords = "Aggregation, Alpha-synuclein, Neuronal cells, Oligomer, Parkinson's disease, Toxicity",
author = "Bin Yuan and Michael Sierks",
year = "2009",
month = "7",
day = "31",
doi = "10.1016/j.neulet.2009.04.046",
language = "English (US)",
volume = "459",
pages = "16--18",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells

AU - Yuan, Bin

AU - Sierks, Michael

PY - 2009/7/31

Y1 - 2009/7/31

N2 - Intracellular clearance of toxic protein aggregates represents a promising therapeutic approach to treat protein-misfolding diseases such as Parkinson's and Huntington's diseases. Intracelluarly expressed antibody fragments or intrabodies can be used to bind specific intracellular targets. Addition of a non-traditional secretion signal sequence enables the intrabody to first bind its target inside the cell and then shuttle the bound target through the cell membrane, secreting it from the cell. We intracellularly expressed two different single chain antibody (scFv) fragments targeting either monomeric or oligomeric alpha-synuclein (a-syn), in a mammalian cell model that overexpresses a-syn. Two versions of each intrabody were studied, one with and one without the non-traditional secretion signal. The scFv targeting monomeric a-syn provided little or no reduction in toxicity induced by overexpression of a-syn, however binding and secretion of oligomeric a-syn totally reduced toxicity. Non-traditional intrabody secretion therefore represents an effective method to target and clear a variety of harmful intracellular species.

AB - Intracellular clearance of toxic protein aggregates represents a promising therapeutic approach to treat protein-misfolding diseases such as Parkinson's and Huntington's diseases. Intracelluarly expressed antibody fragments or intrabodies can be used to bind specific intracellular targets. Addition of a non-traditional secretion signal sequence enables the intrabody to first bind its target inside the cell and then shuttle the bound target through the cell membrane, secreting it from the cell. We intracellularly expressed two different single chain antibody (scFv) fragments targeting either monomeric or oligomeric alpha-synuclein (a-syn), in a mammalian cell model that overexpresses a-syn. Two versions of each intrabody were studied, one with and one without the non-traditional secretion signal. The scFv targeting monomeric a-syn provided little or no reduction in toxicity induced by overexpression of a-syn, however binding and secretion of oligomeric a-syn totally reduced toxicity. Non-traditional intrabody secretion therefore represents an effective method to target and clear a variety of harmful intracellular species.

KW - Aggregation

KW - Alpha-synuclein

KW - Neuronal cells

KW - Oligomer

KW - Parkinson's disease

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=65749095912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749095912&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2009.04.046

DO - 10.1016/j.neulet.2009.04.046

M3 - Article

C2 - 19394405

AN - SCOPUS:65749095912

VL - 459

SP - 16

EP - 18

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -